Related Experiment Video
Updated: Aug 30, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
[Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease]
Insights
The drug pumpan, when added to standard therapy, reduced angina attacks and ST depression in patients with ischemic heart disease. This improves exercise tolerance for individuals with stable effort angina.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Ischemic heart disease (IHD) with stable effort angina (SEA) impacts exercise tolerance.
- Functional class II-III patients experience significant symptoms impacting daily life.
Purpose of the Study:
- To evaluate the efficacy of the drug pumpan in improving exercise tolerance.
- To assess pumpan's effect on exercise-induced myocardial ischemia in IHD patients.
Main Methods:
- A study involving 30 IHD patients with stable effort angina (functional class II-III).
- Patients received standard antianginal therapy with or without the addition of pumpan.
- Exercise tolerance and myocardial ischemia were assessed using bicycle ergometry.
Main Results:
- Pumpan addition to standard therapy significantly reduced the frequency of anginal attacks.
- ST depression during bicycle exercise tests was notably decreased with pumpan.
- Improved exercise tolerance was observed in the group receiving pumpan.
Conclusions:
- Pumpan demonstrates effectiveness as an adjuvant therapy for IHD patients with stable effort angina.
- The drug aids in managing symptoms and improving exercise capacity in this patient group.
- Pumpan can be a valuable addition to existing antianginal treatment regimens.
Aim:
To study effects of the drug pumpan on exercise tolerance and myocardial ischemia induced by exercise in patients with ischemic heart disease of functional class II-III.
Material And Methods:
The study included 30 patients with various forms of ischemic heart disease (myocardial infarction, coronary artery bypass grafting) having stable effort angina of functional class II-III.
Results:
The addition of a compound drug pumpan to a standard antianginal therapy reduced the number of anginal attacks and ST depression at bicycle exercise test.
Conclusion:
Pumpan is an adjuvant medication in conduction of antianginal therapy in ischemic heart disease patients with stable angina of effort of functional class II-III.
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure V: Medical Management
Pathophysiology of Cardiac Performance
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure Drugs: β-Blockers

